MCBC (NASDAQ:MCFT) Given New $44.00 Price Target at Raymond James

Share on StockTwits

MCBC (NASDAQ:MCFT) had its price target hoisted by Raymond James from $36.00 to $44.00 in a report published on Thursday, September 20th. They currently have a strong-buy rating on the stock.

A number of other equities research analysts have also commented on the company. Zacks Investment Research upgraded MCBC from a hold rating to a buy rating and set a $41.00 price target on the stock in a research report on Wednesday, September 19th. B. Riley upped their price target on MCBC from $36.50 to $44.00 and gave the company a buy rating in a research report on Monday, September 17th. BidaskClub upgraded MCBC from a buy rating to a strong-buy rating in a research report on Saturday, September 15th. Robert W. Baird upped their price target on MCBC from $38.00 to $42.00 and gave the company an outperform rating in a research report on Tuesday, September 11th. Finally, ValuEngine upgraded MCBC from a hold rating to a buy rating in a research report on Friday, September 7th. One investment analyst has rated the stock with a hold rating, five have given a buy rating and two have given a strong buy rating to the stock. MCBC currently has a consensus rating of Buy and a consensus target price of $40.33.

MCFT stock traded up $0.08 during midday trading on Thursday, reaching $32.80. 289,663 shares of the stock were exchanged, compared to its average volume of 171,156. The firm has a market capitalization of $671.90 million, a P/E ratio of 16.16, a P/E/G ratio of 1.01 and a beta of 1.04. MCBC has a 52 week low of $20.13 and a 52 week high of $39.50. The company has a quick ratio of 0.33, a current ratio of 0.73 and a debt-to-equity ratio of 1.33.

MCBC (NASDAQ:MCFT) last issued its quarterly earnings data on Thursday, September 6th. The company reported $0.66 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.15. The business had revenue of $95.43 million for the quarter, compared to analyst estimates of $89.29 million. MCBC had a return on equity of 108.42% and a net margin of 11.92%. MCBC’s quarterly revenue was up 63.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.35 EPS. As a group, equities research analysts expect that MCBC will post 2.38 EPS for the current fiscal year.

Institutional investors have recently made changes to their positions in the stock. JPMorgan Chase & Co. boosted its position in shares of MCBC by 308.6% during the 1st quarter. JPMorgan Chase & Co. now owns 16,217 shares of the company’s stock valued at $408,000 after purchasing an additional 12,248 shares in the last quarter. Citadel Advisors LLC boosted its position in shares of MCBC by 24.3% during the 2nd quarter. Citadel Advisors LLC now owns 57,148 shares of the company’s stock valued at $1,654,000 after purchasing an additional 11,182 shares in the last quarter. PNC Financial Services Group Inc. bought a new stake in shares of MCBC during the 2nd quarter valued at about $1,542,000. Dynamic Technology Lab Private Ltd bought a new stake in shares of MCBC during the 2nd quarter valued at about $340,000. Finally, Los Angeles Capital Management & Equity Research Inc. raised its stake in MCBC by 24.4% during the 2nd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 22,094 shares of the company’s stock worth $640,000 after buying an additional 4,340 shares during the period. Institutional investors own 93.79% of the company’s stock.

MCBC Company Profile

MCBC Holdings, Inc, through its subsidiaries, innovates, designs, manufactures, and markets sport boats and outboard boats in North America and internationally. The company's boats are used for water skiing, wakeboarding, wake surfing, and fishing, as well as general recreational boating. It also provides various accessories, such as trailers and aftermarket parts.

Recommended Story: Stock Split

Analyst Recommendations for MCBC (NASDAQ:MCFT)

Receive News & Ratings for MCBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MCBC and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.